The aglycones of the antibiotics eremomycin, vancomycin and ristocetin (3, 4 and 6, respectively) were prepared by deglycosidation of the parent antibiotics with hydrogen fluoride, and complete assignation of their 1 H, 13 C and 15 N spectra was performed. The squaric acid amide esters (11ϳ14), were prepared from dimethyl squarate. The corresponding asymmetric diamides (16ϳ19, 22, 23) were also synthesized using 4-phenylbenzylamine and triglycine. The advantage of the method is the high regioselectivity and that no protecting group strategy is required. Electrospray mass spectroscopic method was elaborated for the determination of the site of substitution of the modified antibiotics. The antibacterial activity of the prepared compounds is discussed in detail.
Introduction
During the past fifty years the chemistry, biology, and therapeutic application of the glycopeptide antibiotics have been continuously progressing [1, 2] . In each of these antibiotics the specific heptapeptide aglycone is substituted at the alcoholic and/or phenolic hydroxyl groups with aminodeoxy sugars and simple, neutral carbohydrates. Based on the substitution pattern, mono-, bis-, tris-, and tetraglycoside-type glycopeptide antibiotics are classified [3] , of which the bis-and tris-glycosides are the most frequently occurring. Until now, no C-or N-glycosidic bond, or a glycosylamine structural unit were detected in the molecules of the glycopeptide antibiotics.
These antibiotics exert biological activity by developing hydrogen bond between the glycopeptide backbone and the L-Lys-D-Ala-D-Ala terminal monomer fragment of the peptidoglycan constituent in the bacterial cell wall. This interaction inhibits the transglycosidation and transpeptidation processes which leads to interruption of ORIGINAL ARTICLE
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Synthesis, Structural and Antibacterial Studies † the cell-wall synthesis and destruction of the bacteria. Interestingly, many glycopeptide antibiotics [vancomycin (2) , eremomycin (1), ristocetin A (5), etc.] form dimeric complexes in aqueous solution [4] .
Preparation of the aglycones of the glycopeptide antibiotics has been attempted by means of chemical methods, i.e. by acid hydrolysis of the parent antibiotics under various conditions. However, these procedures generally led to extremely complex reaction mixtures and low yields. The hydrogen fluoride-method was used by Wanner [5] in glycopeptide chemistry for the deglycosidation of vancomycin, ristocetin and ramoplanin.
In the present work we describe the results obtained by repeating deglycosidation of vancomycin and ristocetin A with hydrogen fluoride, and this procedure was also extended to eremomycin. For comparison of the NMR spectra, the aglycone of teicoploanin was also prepared by acid hydrolysis (Fig. 1) . The synthesis, physico-chemical properties, mass and NMR spectral characteristics and antibacterial activity of the new semisynthetic glycopeptide antibiotics and their aglycones prepared with dimethyl squarate are also presented.
Results and Discussion

Deglycosidation
The cleavage of the O-glycosidic bond of the glycopeptide antibiotics with hydrogen fluoride is greatly influenced by several factors, including the type and number of places of attachments of the neutral sugars and aminodeoxy hexoseseither as a monosaccharide unit or an oligosaccharide chain-to the heptapeptide aglycones.
We observed that deglycosidation of the monoglycosidetype vancomycin (2) and of the bis-glycoside-type eremomycin (1) with HF/anisole under the conditions suggested by the American researchers [5] (Scheme 1) furnished the homogeneous aglyco-vancomycin (4) and aglyco-eremomycin (3) with good yields. The purity of the products was proved by TLC, HPLC, and MALDI-TOF (Table 1) , and the structures were assigned according to the 1 H and 13 C NMR data (Table 2aϳb ). The yields of the reactions were greatly influenced by the temperature and volume of the EtOAc -MeOH mixture (4 : 1) used for washing in work-up procedure.
In contrast to the data described for 1 and 2, deglycosidation of the tris-glycoside-type ristocetin A (5), containing six carbohydrate units, with anhydrous HFanisol mixture (Scheme 2) resulted in 3ϳ4 component reaction mixtures in each case. Purification of the Scheme 1 Deglycosidation of eremomycin and vancomycin [5] . C NMR assignments (Table 2cϳd ). Characterization of 6 was very important in the knowledge of the results reported by Ellestad et al. [6] , who observed epimerization of the methin-group of the N-terminal-4-hydroxyphenylglycine unit of avoparcins. In addition, Herrin et al. [7] performed inversion of the configuration at the N-terminal amino group of aglyco-ristocetin A (ring of ristomycinic acid) by a chemical method to obtain epiaglyco-ristocetin A (7). Thus the R configuration of the named asymmetric center in 6 changed to S in 7.
Preparation of Semisynthetic Glycopeptide Antibiotics
The goal of the development of new series of the glycopeptide antibiotics is to produce analogues active against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VREF) strains.
In a recent work we have successfully applied squaric acid esters, introduced by Tietze et al. [8] , for the chemical modification of anthracycline glycoside antibiotics [9, 10] . It is known that squaric esters (7) selectively react with a small excess of primary or secondary amines in aqueous and/or alcoholic media even in the presence of alcoholic and phenolic hydroxyl, and also carboxyl groups. In neutral media the product is always the squaric acid amide ester (8) , whereas under more alkaline conditions (pH Ͼ7) the corresponding symmetric (9) or asymmetric diamide (10) are produced (Scheme 3).
The reaction of the amino functions of the glycopeptide antibiotics located at N-terimus of the heptapeptide aglycones and at the aminodeoxy sugars with a squaric acid ester would afford mono and diamide or triamide derivatives. The diamides may possess symmetric or asymmetric structure. The primary and secondary N-terminal amino groups of the aglycones are always more reactive than the amino function of the aminodeoxy sugar moieties.
The reaction of the antibiotics 1, 2 and 5 with the squaric acid ester 7, furnished (Scheme 4) the squaric acid amide esters 11, 12 and 13, which spontaneously separated from the reaction mixtures. Due to the slight water-solubility of 6, analogous reaction gave the 14 amide ester of aglycoristocetin A only in a 1:1 methanol-buffer (pH ϳ7) mixture. The best yields were obtained with 5 and 6, carrying an N-terminal primary amino group, to give the squaric acid amide estes 13 and 14 of ristomycin A and aglyco-ristomycin A, respectively.
The homogenity/purity of the above squaric acid amide esters was investigated by TLC and HPLC, and their structures were substantiated by means of MALDI-TOF mass spectrometry, the UV spectral data (l max ϭ277ϳ 281 nm), characteristic of the glycopeptide antibiotics (Table 3 ), and by the 1 H and 13 C NMR spectra (Table 5) . Theoretically, it cannot be excluded that besides hydrogen-bonding, the antibiotic squaric acid amide esters 11ϳ14 can bind to the peptidoglycan fragment of the bacterial cell wall also with covalent bonding at an appropriate pH.
Of the numerous, known semisynthetic derivatives [2, 11ϳ16] the most active are those in which the amino group of the heterodisaccharide side-chain is substituted either with a bulky aromatic group, or a longer alkyl chain. We decided to enhance the lipophilic character of the glycopeptide molecules by reacting compounds 11ϳ14 with 4-phenylbenzylamine (15) to furnish the asymmetric diamides 16ϳ19 (Scheme 4). The characteristic physicochemical and NMR data are summarized in Tables 4 and 5,   570 respectively. Scheme 5 shows that the reaction of the N-terminal amino group of the aglycone of the glycopeptide antibiotics with dimethyl squarate results first in the reactive squaric acid amide esters, whose treatment with the selected amino compound leads to the target amides. However, such asymmetric molecules can also be constructed (Scheme 5) by the preparation of the reactive vinylamide-type squaric acid half-ester 21 from dimethyl squarate (7) and triglycine (20) , followed by reaction with the N-terminal amino group of 5 or its aglycone 6 under basic conditions (pH Ͼ8) to obtain the target molecules 22 and 23. The advantage of both methods is that because of the high regioselectivity no protecting group strategy is needed to perform the experiments.
Mass Spectrometry
In the reaction of the antibiotics with dimethyl squarate we observed the formation of a single product, the site of the attachment was unknown. Theoretically, from eremomycin three types of monosquaramide can be obtained, from vancomycin and ristocetin A two possible regioisomers can be deduced. We solved this problem using electrospray mass spectrometry. A preliminary experiment was done on the protonated molecular ion of 19 to see the tandem mass spectrometric behavior of the squaric acid-modified aglycone. The loss of the squaric acid moiety was found to be the most characteristic process. In the eremomycin derivative 16 there are three possible places to which the squaric acid may be bond: the two amino sugar moieties and the Nterminus of the peptide core. The molecular weight of 16 (1819.2) is out of the mass range of the instrument so the doubly charged ion at m/zϭ910.3 was selected as precursor in the EPI experiment. Singly and doubly charged ions are also appeared in the spectrum. The most intense peak in the spectrum at m/zϭ1676.3 is formed by loss of 144 Da. The mass of both R 2 and R 3 (for abbreviations see Scheme 1 and 2) is 144 but the consecutive loss of 305 Da resulting a peak at m/zϭ1371.1 clearly shows that the former is due to 572 Scheme 3 The squarate linker method [8] . the loss of R 3 and the latter is that of the disaccharide chain containing R 2 , respectively. Peaks in the lower m/z region at 144 and 306 are correspondent to the R 1 and to the disaccharide unit with R 2 , respectively. No peaks could be found in the spectrum corresponding to the combination of either of the two aminosugars and the squaric acid ( Figure  2 ). From these data it can be concluded that the squaric acid was bonded to the N-terminus of the peptide chain. There are only two possible positions for the reaction with squaric acid in vancomycin, i.e. the R 2 and the Nterminus. The EPI experiment with derivative 17 was done on the doubly charged molecule (856.3). The spectrum obtained is quite simple, only several peaks appeared.
The most intense peak at m/zϭ1406.2 is attributed to corresponding to the loss of the disaccharide unit with R 2 . This is only possible if the squaric acid is linked at the N-terminus in the molecule (Figure 3) .
The EPI spectrum of the doubly charged ristocetin derivative 18 seemed the most complicated among the spectra of antibiotics examined, and this is due to the number and complexity of the carbohydrate side chains. There are two possible positions of the squaric acid: at the aminosugar (R 2 ) and at the X 2 . The combination of the consecutive losses of R 1 R 2 R 3 and 167 Da (biphenylmethyl group from the squaric acid part) can be found in the spectrum (Figure 4 ). There are two peaks in the spectrum at 573 Scheme 4 Preparation of the squaric acid amide esters and asymmetric diamides. m/zϭ1598.2 and 1436.2, corresponding to the loss of R 1 ϩR 2 and R 1 ϩR 2 ϩR 3 , respectively, containing the squaric acid moiety but not an aminosugar portion. The latter has the same mass as the protonated molecular ion of the aglyco-ristocetin A derivative 19. These data support our assumption that the sqaric acid is connected to the antibiotic at position X 2 . 13 C NMR analysis, however 15 N data are sparse (missing for aglycones). It has been demonstrated that 15 N chemical shifts are extremely useful for locating H-bonds [17, 18] while 15 N relaxation gives more insight into dynamics [19] . 
Fig. 3 Enhanced product ion (EPI) spectrum of the doubly charged vancomycin derivative (17).
Fig. 4 Enhanced product ion (EPI) spectrum of the doubly charged ristocetin-A derivative (18).
SA represents the squaric acid moiety.
Pioneer NMR assignments are difficult to compare, since the experimental conditions and methods are very different. In aqueous solution, many glycopeptide antibiotics form asymmetric dimers, and therefore experiments were often carried out in DMSO solution, at high temperature to get rid of exchange broadened peaks. Certain derivatives, including the aglycones, are poorly soluble in water. Early aglycone assignments were mostly based on chemical shift comparison and homonuclear correlations; e.g. for teicoplanin [20] and vancomycin [21, 22] , eremomycin [23] . The assignment strategy for the aglycones was similar to our earlier methods, however in this work the starting points were the amides that were identified from the 15 N HSQC-spectra ( Figure 5 ). The main chain 1 H assignment of the heptapeptide core was augmented with homonuclear NOESY in addition to COSY and TOCSY spectra. Sequential NH-NH NOE-s can be observed at the Nterminus up to residue 4, because of the b -sheet like secondary structure [24] . Due to limited homonuclear connectivites 13 C assignments were based on 13 C-1 H HSQC and HMBC spectra for detecting one-bond and long-range heteronuclear connectivities. The latter was especially useful for the assignments of the aromatic rings. The NMR assignments of the four aglycones are grouped in tables (Table 2a, 2b Table 2c , 2d) containing the vancomycineremomycin and ristocetin-teicoplanin pairs. It can be seen that the independent (self-consistent) full assignments of the pairs are well comparable, lending further support to their reliability. Furthermore, comparison with earlier assignments of the intact eremomycin and its aglycone [23] supports that the aglycone does not form dimers in DMSO solution, in contrast to eremomycin in aqueous solution. This is proved by the 1 H chemical shift of the 6e proton (d ϭ6.89 ppm) in the monomeric aglycone, in contrast to 5.3 ppm in the dimer, where the unusual aromatic shift is due to orthogonal s-p interaction between H-6e and ring 4. ACD chemical-shift prediction software [25] proved to be useful: though it was insufficient for predicting small chemical shift differences. Because of better solubility and resolution we gave the assignments of the ristocetin aglycone in methanol solution.
Squaric Acid Derivatives of the Glycopeptide Aglycones
In Table 5 we present only the assignments of the substituents attached the glycopeptide aglycones. The presence of the aglycones was proved by overlaying their 2D-HSQC spectra with the appropriate aglycone, although it is occasionally complicated with signal-doubling due to the presence of the amide group restricted rotation in the squaric acid [8] . Therefore, some assignments are missing (see as ND label) due to low signal-to noise ratio in their 13 C NMR spectra. However, in such cases, mass spectra were convincing about the identity of the semisynthetic derivatives and the site of the squaric acid attachment.
Antibacterial Activity
The aglycones are responsible for the biological activity of 577 the molecules are not listed, though they were unambiguously detected in the overlayed 2D HSQC spectra according to the assigned spectra of the aglycones.
the glycopeptide antibiotics. The antimicrobial activities of the aglycones, obtained after removal of the carbohydrate moieties, in comparison with those of the parent antibiotics are summarized in Table 6 . Deglycosydation of eremomycin (1) to 3 results in a surprising decrease in the activity against all of the tested seven microorganisms. The activity of aglyco-vancomycin (4) against Bacillus subtilis decreased to more than the half of the original value, and ca. to the half against methicillinsensitive and resistant Staphylococcus aureus (MSSA, MRSA) and S. epidermidis (MRSE, MSSE).
According to Boger [26] , the elemental composition and structural features of the aglycones 3 and 4 are very similar, and-besides the atropisomerism (rings 5 and 7) of actinoidinic acid-the chloro substituent of the aromatic rings of 2 and 6 has a complementary role in the affinity and selectivity of binding to the L-Lys-D-Ala-D-Ala tripeptide of the bacterial cell wall. By comparing the antibiotic activity of 1 and 3 and 6, Russian researchers came to the same conclusion [14, 15] .
In the case of ristomycin A (5), the aglyco-ristomycin (6), which does not carry a covalent chloro atom, a positive change in the activity against both MSSA and MRSA was observed. This aglycone (6) was found twice as active against MRSA as the parent antibiotic (5) . As compared to 5, the activity of 6 against both Enterococcus faecalis strains dropped to half, and to one-fourth against B. subtilis. The MIC values for 6 and 2 are approximately the same obtained with the organisms S. aureus, S. epidermidis and E. faecalis. Moreover, these efficacies compare favourably [30] to those of the new synthetic oxazolidinone derivative, linezolid which is in clinical use.
The antibacterial activity of the of the squaric acid amide esters 11 and 13, derived from eremomycin and ristocetin A, against the test microorganisms is much decreased as compared to both of the parent antibiotics 1 and 5, and to the corresponding aglycones. At the same time, the squaric acid amide ester of aglyco-ristocetin (14) possesses lower decrease in activity than compound 13.
Of the asymmetric squaric amides 18 and 19, derived from ristocetin A (5) and aglyco-ristocetin A (6), respectively, with 4-phenylbenzylamine (15), the activity of 18 significantly increased against B. subtilis and E. faecalis (VSEF, GREF).
Except for MRSA, the effectiveness of 19 is higher than that of 14 towards each of the investigated bacterial strains, and practically identical with that of the starting aglycone 6.
Experimental
The samples of eremomycin, ristocetin A and aglycoteicoplanin were received from the Gauze Institute of New Antibiotics (Moscow). Vancomycin hydrochloride was purchased from Aldrich Co.
The solutions were evaporated under diminished pressure at 40°C. Preparative column chromatography was performed on Silica gel 60 (0.063ϳ0.2 mm, Merck) and Silica gel 60 silanized (0.063ϳ0.2 mm, Merck) adsorbents. HPLC was carried out with a Waters 600 instrument using UV detection at 230 nm. Column: Lichrospher RP-8 (4ϫ250 mm 10 m m); injection volume: 20 m l (from 0.1 mg/ml). Eluent A: CF 3 COOH-H 2 O (pHϭ2.65); B: 579 C and 15 N channels) was used. Simple, gradient-enhanced magnitude representation COSY-60 spectra were run with solvent presaturation when necessary. Gradient and sensitivity enhanced TOCSY spectra were acquired with DIPSI2 mixing sequence of 60 ms. 13 C-1 H and 15 N-1 H HSQC spectra were obtained with gradient and sensitivity enhancement ( 15 N spectra required overnight accumulation at natural abundance). The used NOESY pulse sequence was equipped with the Hahn spin-echo to remove broad solvent lines and baseline bias. The same spin-echo technique was applied in 1D 1 H signal accumulation. In case of derivatives, straight 13 C accumulation was sometimes a bottleneck, because of the low 13 C sensitivity of the inverse probe. Therefore, in such cases, the basic acquisition scheme of 30°1 3 C read pulse was applied, instead of the more informative J-modulated spin-echo sequence. The gradient enhanced HMBC sequence was preceded with a filter to suppress one-bond correlations and 13 C decoupling was applied during acquisition. SPARKY software package [31] was used for visualization and assignment.
For the deglycosidation experiments a Toho Kasei (Japan) apparatus at the Department of Organic Chemistry, Lóránd Eötvös University of Budapest was used.
Deglycosidation of Eremomycin and Vancomycin
Deglycosidation of eremomycin and vancomycin was carried out as described earlier by Wanner et al. [5] (25°C, 2 hours). The physico-chemical data of the prepared aglycones 3 and 4 are collected in Table 1 , and the NMR data are presented in Tables 2aϳb.
Preparation of Aglyco-ristocetin A (6)
In the teflon tube of the deglycosidation instrument anisole (1.9 ml) was added to ristocetin A sulfate (5200 mg), the mixture was cooled to Ϫ70 to Ϫ80°C and 50 ml of HF was added. The excess of HF was then removed through a CaO trap in vacuum at Ϫ18°C. The crude reaction product was washed three times with an ice-cold 4 : 1 ethyl acetatemethanol mixture, filtered and dried in a vacuum desiccator. The product contained three UV-detectable components on TLC.
Column Chromatography The crude aglycone was dissolved in methanol, containing a small amount of acetic acid (6 ml methanolϩ2 drops of AcOH), and it was applied onto the surface of Silicagel 60 (3.0 g) by evaporation. The residue was applied to the top of a Silicagel 60 (0.063ϳ0.2 mm) column (50ϫ2 cm), and gradient elution was performed with toluene -MeOHAcOH (7 : 3 : 0.1)→toluene -MeOH -AcOH (6 : 4 : 0.1). The fractions with Rf: 0.26 was collected, evaporated and dried in a vacuum desiccator to furnish 1.50 g (52.8%) of 6, whose physical and NMR data are shown in Tables 1 and  2cϳd , respectively.
Synthesis of the Squaric Acid Amide Esters 11ϳ14 of the Glycopeptide Antibiotics and Their Aglycones
To a solution of the antibiotic/aglycone 1ϳ6 (0.1 mmol) in Tristisol buffer (5.0 ml, pHϭ7.3) dimethyl squarate (7, 0.1 mmol) was added at room temperature, and the mixture was stirred at the same temperature overnight. The resulting precipitate was filtered off, and washed three times with distilled water (3.0 ml), methanol and ether (3.0ϳ3.0 ml). Column chromatographic purification (6 : 4 : 0.0.25 toluene -MeOH -AcOH) was necessary only in the case of 14. The yields and the physico-chemical data for the products 11ϳ14 are shown in Table 3 , and the NMR characteristics are collected in Table 5 .
Preparation of the Asymmetric Squaric Acid Amides (16ϳ19, 22, 23) of the Glycopeptide Antibiotics and Their Aglycones
Method A The squaric acid amide esters 11ϳ14 (0.1 mmol) were dissolved in a mixture (pH Ͼ8) of water (4.0 ml), methanol (4.0 ml) and triethyl amine (0.01 ml), and then 4-phenylbenzylamine (15, 0.1 mmol) was added. The reaction mixture was stirred overnight, and concentrated under diminished pressure. The residue was washed with methanol and water (3.0ϳ3.0 ml) and dried in a vacuum desiccator over CaCl 2 Method B. The Reverse Method Dimethyl squarate (7, 0.5 mmol) and triglycine (20, 0.5 mmol) were dissolved in a mixture of N,N-dimethyl formamide (6.0 ml) and Tristisol buffer (2.0 ml, pH Ͼ7), and the mixture was stirred at room temperature for 28 hours. Evaporation of the reaction mixture under diminished pressure afforded the squaric acid triglycine amide 21, which was purified by column chromatography (eluent: 4 : 1 : 1 nBuOH -AcOH -H 2 O, Rfϭ0.46). Compound 5 or 6 (0.5 mmol) was dissolved in a mixture of Tristisol buffer (20 ml) and MeOH (30 ml), then 21 (0.5 mmol) was added and the pH was adjusted to 8.0. The reaction mixture was strirred at room temperature for 48 hours, the precipitated product was filtered off, washed with water and 50% aquoeus methanol and dried in a vacuum desiccator. The physico-chemical data and NMR spectral characteristics of 22 and 23 are given in Tables 4 and 5 , respectively.
Antibacterial Activity Testing
Bacterial Strains
The antibacterial activities of the preparations and their derivates were measured on B. subtilis ACTC 6633, methicillin-sensitive S. aureus ACTC 29213 (MSSA), methicillin-resistant S. aureus ACTC 33591 (MRSA), methicillin-resistant S. epidermidis IMMSU12333/05 (MRSE), vancomycin-and teicoplanin-sensitive E. faecalis ACTC 29212 (VSEF), and vancomycin-resistant but teicoplanin-sensitive E. faecalis ACTC 51299 (VREF) strains. The confirmation of the presence and absence of the vanAϳB and mecA genes was done as previously described [27, 28] .
Susceptibility Test
In all cases, except for linezolid, the efficacy of the antimicrobials was determined with the broth micro dilution method according to the NCCLS guideline [29] . Bacterial strains were grown on 5% bovine blood agar plates at 35°C overnight. Appropriate numbers of colonies were suspended in physiological saline in order to reach the density of 0.5 McFarland for inoculation.
Stock solutions of different concentrations of the antimicrobials were prepared in either distilled water or water -methanol (1 : 1) or in water -DMSO (1 : 1) depending on the solubility of the given preparation. These were two-fold serially diluted from 256 to 0.5 m g/ml in cation-adjusted Mueller-Hinton broth then 100 ml of each dilution was transferred into microplate's holes. Inoculation occurred with 10 m l of each of the bacterial suspensions. Incubation was performed at 35°C for 18 hours and reading of minimal inhibitory concentration (MIC) was made with the naked eyes on a mirror.
Solvents were also tested for inhibition of bacterial growth. None of them exerted bacteriostatic effect at the concentration used.
MICs for linezolid were determined with the E-test on cation-adjusted Mueller-Hinton agar plates according to the instructions of the manufacturer (AB Biodisk, Solna, Sweden).
